Advertisement
Review Article| Volume 26, ISSUE 4, P629-631, October 2010

Immunologic Changes in Obesity

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Winkelman C.
        • Maloney B.
        Obese ICU patients: resource utilization and outcomes.
        Clin Nurs Res. 2005; 14: 303-323
        • Weisberg S.P.
        • McCann D.
        • Desai M.
        • et al.
        Obesity is associated with macrophage accumulation in adipose tissue.
        J Clin Invest. 2003; 112: 1796-1808
        • Gordon S.
        • Taylor P.R.
        Monocyte and macrophage heterogeneity.
        Nat Rev Immunol. 2005; 5: 953-964
        • Odegaard J.
        • Ricardo-Gonzalez R.
        • Goforth M.
        • et al.
        Macrophage-specific PPARγ controls alternative activation and improves insulin resistance.
        Nature. 2007; 447: 1116-1120
        • Tontonoz P.
        • Hu E.
        • Spiegelman B.M.
        Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor.
        Cell. 1994; 79: 1147-1156
        • Karagiannides I.
        • Pothoulakis C.
        Obesity, innate immunity and gut inflammation.
        Curr Opin Gastroenterol. 2007; 23: 661-666
        • Vitseva O.
        • Tanriverdi K.
        • Tchkonia T.
        • et al.
        Inducible toll-like receptor and NF-κB regulatory pathway expression in human adipose tissue.
        Obesity. 2008; 16: 932-937
        • Auwerx J.
        PPARγ: a versatile metabolic regulator.
        Int J Obes. 2000; 24: S4
        • Plotkin B.
        • Paulson D.
        • Chelich A.
        • et al.
        Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa = fa): susceptibility to Candida albicans infection and leucocyte function.
        J Med Microbiol. 1996; 44: 277-283
        • Martin-Romero C.
        • Santos-Alvarez J.
        • Goberna R.
        • et al.
        Human leptin enhances activation and proliferation of human circulating T lymphocytes.
        Cell Immunol. 2000; 199: 15
        • Fantuzzi G.
        • Faggioni R.
        Leptin in the regulation of immunity, inflammation and hematopoiesis.
        J Leukoc Biol. 2000; 68: 437-446
        • Falagas M.
        • Kompoti M.
        Obesity and infection.
        Lancet Infect Dis. 2006; 6: 438-446
        • Arsenijevic D.
        • Onuma H.
        • Pecqueur C.
        • et al.
        Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production.
        Nat Genet. 2000; 26: 435-439
        • Lord G.
        • Matarese G.
        • Howard J.
        • et al.
        Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression.
        Nature. 1998; 394: 897
        • Nijhuis J.
        • Rensen S.
        • Slaats Y.
        • et al.
        Neutrophil activation in morbid obesity, chronic activation of acute inflammation.
        Obesity. 2009; 17: 2014-2018
        • Loskutoff D.J.
        • Samad F.
        The adipocytes and hemostatic balance in obesity: studies of PAI-1.
        Arterioscler Thromb Vasc Biol. 1998; 18: 1-6
        • Goldstein B.
        • Scalia R.G.
        • Ma X.
        Protective vascular and myocardial effects of adiponectin.
        Nat Clin Pract Cardiovasc Med. 2009; 6: 27-35
        • Okamoto Y.
        • Kihara S.
        • Ouchi N.
        • et al.
        Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.
        Circulation. 2002; 106: 2767-2770
        • Ohashi K.
        • Kihari S.
        • Ouchi N.
        • et al.
        Adiponectin replenishment ameliorates obesity-related hypertension.
        Hypertension. 2006; 47: 1108-1116
        • Okamoto Y.
        • Arita Y.
        • Nishida M.
        • et al.
        An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls.
        Horm Metab Res. 2000; 32: 47-50
        • Tao L.
        • Gao E.
        • Jiao X.
        • et al.
        Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.
        Circulation. 2007; 115: 1408-1416
        • Shibata R.
        • Sato K.
        • Pimentel D.
        • et al.
        Adiponectin protects against myocardial ischemia-reperfusion injury through AMP kinase- and COX-2-dependent mechanisms.
        Nat Med. 2005; 11: 1096-1103
        • Jay D.
        • Hitomi H.
        • Griendling K.
        • et al.
        Oxidative stress and diabetic cardiovascular complications.
        Free Radic Biol Med. 2006; 40: 183-192